Invited Faculty
The chart is organized in alphabetical order by last name.
-
Mahesh Bahadur Adhikari
Principal Consultant & Head, Department of Urology, Nepal Mediciti, Nepal
Mahesh Bahadur Adhikari
Principal Consultant & Head, Department of Urology, Nepal Mediciti, Nepal
-
Ketan Badani
Vice Chair, Department of Urology, Mount Sinai Health System, United States
Ketan Badani
Vice Chair, Department of Urology, Mount Sinai Health System, United States
Dr. Ketan K. Badani is Professor of Urology, Icahn School of Medicine at Mount Sinai, Vice Chairman of Urology and Robotic Operations at the Mount Sinai Health System, Director of Robotic Surgery at Mount Sinai West, Director of the Comprehensive Kidney Cancer Center and Reconstructive Urology at Mount Sinai Health System and Chief, Surgical Innovation and Strategy – Mount Sinai West and Morningside Hospitals. Dr. Badani is a compassionate and engaged urologist based in New York, NY. Dr. Badani graduated at the top of his class from Case Western Reserve school pf Medicine in Cleveland. He went on to complete his urology residency at the world renown Vattikuti Urology Institute at Henry Ford Hospital in Detroit. He has also completed a fellowship in minimally invasive urologic oncology at the Vattikuti Urology Institute, where robotic urologic surgery was first performed in the United States. Dr. Badani is known as a world leader in the research and treatment of urologic oncology. With a focus on prostate and kidney cancer, he has led teams and published techniques for minimally invasive robotic kidney cancer surgery. His technique for a partial nephrectomy, F.A.S.T (First Assistant Sparing Technique) has been published and taught around the world to help patients with renal tumors. Dr. Badani has the largest combined experience in robotic kidney and prostate cancer surgery in the New York area. Having performed over 4,000 robotic procedures in his career, he is in the top 1% of urologist worldwide. His clinical expertise covers both surgical and non-surgical approaches to treatment of urologic cancers.
-
Mahendra Bhandari
CEO and Scientist Emeritus VUI, Vattikuti Foundation and the Vattikuti Urology institute Henry Ford Hospital Detroit, United States
Mahendra Bhandari
CEO and Scientist Emeritus VUI, Vattikuti Foundation and the Vattikuti Urology institute Henry Ford Hospital Detroit, United States
MD MBA Urologist, kidney transplant surgeon. Involved with the development and dissemination of Robotic Surgery across the globe.since 2006. Prior to that held academic and senior admin positions in India for 38 years.Founder Editor Indian Journal of Urology.Past President Urology Society of India and Asian Society of Transplantation. Member Editorial Board British Journal of Urology 1985-2000, Member AUAAnd EAU. Research: Artificial intelligence applications in Urology and Surgical safety
-
Tai-Lung Cha
Distinguished Investigator and Director, National Institute of Cancer Research, Taiwan
Tai-Lung Cha
Distinguished Investigator and Director, National Institute of Cancer Research, Taiwan
Educational background 1983/7-1990/8 Bachelor of Medicine, National Defense Medical Center School of Medicine 2000/8-2005/8 Ph.D., Molecular and Cellular Oncology Department, University of Texas MD Anderson Cancer Center Positions held 1992/8-1997/6 Resident physician, General Surgery Division, Tri-Service General Hospital 1997/7-1998/7 Chief resident physician, General Surgery Division, Tri-Service General Hospital 1998/8-2000/7 Attending physician, General Surgery Division, Tri-Service General Hospital 2005/8/14 Lieutenant Colonel, Urological Surgery Division, Tri-Service General Hospital 2006/1-2006/7 Education Training Officer, Urological Surgery Division, Tri-Service General Hospital 2006/8-2009/2 Director of Ward 33, Civilian Department Task Force, Tri-Service General Hospital 2006/11/16 Instructor of Orthopedics, National Defense Medical Center School of Medicine 2006/11-2009/8 Assistant Professor of Surgery, National Defense Medical Center School of Medicine 2010/5/1-2010/7 Lieutenant Colonel Associate Professor and Director of Division of Urology, Department of Surgery, National Defense Medical Center 2010/8/1-2016/1 Colonel Associate Professor of Department of Surgery and Director of Division of Urology, Department of Surgery, National Defense Medical Center 2012-2016 Director of the Taiwan Urological Association 2016-2018 Executive Director of the Taiwan Urological Association 2016/2/-2016/7 Colonel Professor and Director of Department of Surgery, National Defense Medical Center 2016/8-2018/3 Director of the National Defense Medical Center School of Medicine 2016/8-2017/7 Deputy Superintendent of Medical Education, Tri-Service General Hospital 2017/8-2018/3 Vice President of the National Defense Medical Center and Executive Officer of Tri-Service General Hospital 2018-2020 Director of Taiwan Urological Association 2018/3-present Member of the Physical and Mental Disability Task Force, Ministry of Health and Welfare 2018/3-present Director of the Taiwan Surgical Association 2018/4-2019/5 Major General and Director of Department of Military Medicine, ROCA Logistics Command 2019/6- present Major General and President of the National Defense Medical Center 2019/6- present Chairperson of the National Defense Medical Center Alumni Support Foundation for Alma Mater Development 2019/9- present Member of the Ministry of Education Diploma Review Committee for Grudates from Departments of Medicine, Departments of Dentistry, and Departments of Traditional Chinese Medicine in Foreign Universities 2019/11- present Part-time Researcher at the Genomics Research Center, Academia Sinica 2019/11- present Director of the Taiwan Association of Medical Education 2020- present Executive Director of the Taiwan Urological Association 2020/1- present Convener of the Urologic Cancer Clinical Expert Advisory Group, a 2022 Cancer Diagnosis and Treatment Quality Certification and Core Index Project by the National Health Research Institutes 2020/9-2023/9 Director of the Acer Foundation 2021/6- present Member of the Ministry of Education Diploma Review Committee for Grudates from Departments of Medicine, Departments of Dentistry, and Departments of Traditional Chinese Medicine in Foreign Universities 2021/8-2024/7 Member of the 8th Taiwan Medical Accreditation Council 2022/1-2022/12 Convener of the Division of Nephrology, Urology, and Endocrine Medicine, Department of Life Sciences, Ministry of Science and Technology 2022/9-2026/8 11th Director of Cheng Hsin Medical Foundation 2022/11-2025/11 Executive Director of the Taiwan Association of Medical Education 2023/1-2023/12 Convener of the Division of Nephrology, Urology, and Endocrine Medicine, Department of Life Sciences, National Science and Technology Council 2023/2-2026/2 Supervisor at the Institute for Biotechnology and Medicine Industry 2023/1-2023/12 Member of the 25th Appointment Qualification Review Committee of National Health Research Institutes 2023/2-2026/1 Honorary Consultant at the Center for Biomedical Engineering in Cancer, Chung Yuan Christian University 2023/5-2024/12 Municipal Advisor, Taipei City Government 2024/8- present Distinguished Investigator, Director, National Institute of Cancer Research, National Health Research Institutes
-
Allen W. Chiu
Urological Association of Asia, Taiwan
Allen W. Chiu
Urological Association of Asia, Taiwan
-
Simone Crivellaro
Department of Urology, College of Medicine, University of Illinois at Chicago, United States
Simone Crivellaro
Department of Urology, College of Medicine, University of Illinois at Chicago, United States
-
John Davis
Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, United States
John Davis
Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, United States
-
Yuki Endo
Department of Urology, Nippon Medical School Hospital, Japan
Yuki Endo
Department of Urology, Nippon Medical School Hospital, Japan
2022/10 Assistant Professor , Nippon Medical School department of Urology
-
Masatoshi Eto
President, Japanese Urological Association, Japan
Masatoshi Eto
President, Japanese Urological Association, Japan
Masatoshi Eto is a professor and chairman of Department of Urology, Graduate School of Medical Sciences, Kyushu University. He graduated from Faculty of Medicine, Kyushu University in 1986 and obtained MD degree. In 1988, he entered to Graduate School, Division of Medical Science, Kyushu University (Department of Immunology, Medical Institute of Bioregulation) and obtained Doctor of Medical Science (equivalent to PhD) in 1992. After his residency in Urology at Kyushu University Hospital and clinical fellow at various hospitals, he studied abroad at University of Pittsburgh for 2 years from 1999 to 2001. After studying abroad, he became a lecturer at Kyushu University Hospital. Then he moved to Department of Urology, Kumamoto University as a professor and chairman in 2009. From 2015 to present, he has been a professor and chairman of Department of Urology, Graduate School of Medical Sciences, Kyushu University. In addition, from 2018, he is a director of Department of Advanced Medicine and Innovative Technology, Kyushu University Hospital, and a director of Center for Advanced Medical Innovation, Kyushu University. From 2023, he is a president of JUA.
-
Howard Goldman
Professor, Glickman Urologic Institute, Cleveland Clinic, United States
Howard Goldman
Professor, Glickman Urologic Institute, Cleveland Clinic, United States
Howard B. Goldman is a Professor on the faculty of the Cleveland Clinic Lerner College of Medicine and an expert in quality and patient safety serving as the Institute Vice Chairman for Clinical Affairs at the Glickman Urologic Institute. He served as interim Chairman of the department from 2024 to February 2025. He has a joint appointment in the departments of urology and obstetrics and gynecology and is actively involved in the training of fellows and residents, including serving as the Fellowship director for Female Pelvic Medicine and Reconstructive Surgery in the Department of Urology at the Cleveland Clinic. He has directly trained over 40 fellows and residents who are specialized FPMRS practitioners. Many of these fellows have assumed leadership roles in academic urology and many have also become quality and patient safety experts at their local institutions. Dr Goldman’s interests are in the medical and surgical treatment of urinary incontinence and other types of voiding dysfunction, neuromodulation, prolapse repair, complex reconstructive female urologic surgery, robotic surgery and neurourology. His contributions to the literature have been prolific, including author of over 250 articles and book chapters, editor of three textbooks and panel member for a number of standardization, guidelines and best practice statement panels. He has deliverd over 500 national and international lectures. He has been at the forefront of outpatient robotic surgery within FPMRS. Within the AUA he has been on the SUI Guidelines as well as Urodynamics guidelines committees. Within ICS he has been on the male LUTS terminology committee as well as the ICS/IUGA female prolapse terminology committee. He also led the group that came up with the ICS sacral neuromodulation best practices document. His prominent international reputation has led to invitations as visiting professor in the United States and abroad as well as numerous invited lectures. He is on the editorial board of a number of journals and is a former Assistant Editor of the Journal of Urology. He has been the co-director of the AUA annual review course for part 1 of the ABU exam for 10 years, was on the AUA Education committee, is on the SUFU board of directors, was on the International Neurourology board of directors, is on the IUGA scientific committee, is the Chair of the ICS Education committee, was the scientific co-chair for the 2020 ICS annual meeting, was the program co-chair for the 2020 SUFU meeting, was on the program committee for the 2020 International Neurourology Society and is the International Consultation on Incontinence committee chair for surgery for male incontinence. Dr Goldman has been involved in and led numerous projects related to innovative treatments utilizing stem cells for SUI, neuromodulation, utilization of urodynamics, management of complications, robotic surgery and improvements in safety and efficiency in pelvic floor surgery. Recently, he was the clinical lead on an innovative urodynamics device which can stay in the bladder and record events for up to 24 hours without any external catheters. He is also leading a study on the efficacy of sacral neuromodulation in patients with cognitive impairment.